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Abstract: 
Cyclophosphamide is an antineoplastic drug that has many useful effects in cancer treatment, but it has toxic effects 
due to induced free radicals. In this study the effects of L-carnitine as an antioxidant drug on testis tissue and its 
sexual hormones was investigated. 48 adult male wistar rats were selected randomly and divided to 6 groups 
including :control, sham (received normal saline) , cyclophosphamide received  group  ( 5 mg/kg), and experimental 
groups 1, 2, and 3 (receiving 250, 500, and 1000 mg/kg doses of L-carnitine, respectively). L-carnitine and normal 
salin were administered as gavage. After dissection, the rats' testes were removed and put in 10% formalin for 
fixation and slides preparation processes were carried out. Also their serum samples were separated in order to 
measure the LH,FSH and testosterone with eliza. The results revealed a significant decrease in number of 
spermatogonia, spermatocyte, spermatids, sertoli, leydig cells, LH, FSH and testosterone hormones in rats that 
received cyclophosphamide in compared to control and sham groups(P≤0.05). So the results revealed an increase in 
the number of sexual cells, and sexual hormones in the under treatment with L-carnitine high dosage groupes 
compared to cyclophosphamide group (P≤0.05).  
The concurrent use of cyclophosphamide and L-carnitine can decrease the cyclophosphamide toxic effects on testes 
tissue and its sexual hormones.  
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INTRODUCTION: 
Chemotherapy and radiation therapy are associated 
with many changes in the reproductive system, and 
among these agents alkylated drugs have the most 
adverse effects on gonads [1]. Today, especially in 
developed countries, successful treatment of 
malignancies And the life expectancy of these people 
has increased significantly, and most of these people, 
especially young people, tend to have fertility and 
childbirth after recovery[2]. Cyclophosphamide is an 
anti-neoplastic drug (an anticancer drug) that 
converts to an active metabolising metabolite with 
the same effects as mostin (an anti-cancer drug) in the 
body. The cyclophosphamide is well absorbed from 
the gastrointestinal tract and is widely distributed in 
body tissues and fluids and passes through the blood-
brain barrier. This drug is converted into active 
metabolites in the liver and eventually excreted 
through the kidneys[3]. Studies have shown that 
cyclophosphamide is a teratogen in mice, rats, 
rabbits, and monkeys with much lower amounts than 
humans. Its use in humans has led to the production 
of natural and abnormal infants (including the 
absence of fingers and legs, heart abnormalities and 
hernias) [3]. Considering the above and considering 
the antico-plastic effects of cyclophosphamide, a 
study to find ways to reduce complications from 
chemotherapy is very important. Nowadays, methods 
used to prevent infertility after chemotherapy are 
freezing testicular and ovarian tissue, increasing the 
resistance of the stem cells of the stem cells, and 
helping to maintain or regenerate these cells, while 
retaining Cells are more commonly used in 
chemotherapy than other methods [4](2004, Fossa 
and Magelssen). Biological compounds with 
antioxidant properties are capable of Protect cells and 
tissues from disorders caused by active oxygen 
species and free radicals [5,6]. Therefore, 
administration of antioxidants during chemotherapy 
is necessary in order to reduce oxidative stress and to 
detoxify tissues. In other words, simultaneous 
administration of antioxidants and chemotherapy 
drugs reduces the toxicity of reproductive toxicity 
[7]. One of the materials found by researchers is the 
L-carnitine antioxidant with the chemical formula 
beta-hydroxy-gamma-nitro-aminobutric acid, which 
is found to be high in meat and dairy products. L-
carnitine is made from lysine and methionine amino 
acids and plays an important role in the transmission 
of free fatty acid to the mitochondrial matrix in the 
beta-oxidation process [8] (Stephens et al., 2007). 
Research has shown that L-carnitine plays a positive 
role in sperm motility and metabolism [9] by 
supplying the energy needed for sperm. The 
concentration of L-carnitine in the epididymis and 
sperm is 2000 times greater than that in plasma. It 
also protects the cell membrane and DNA, from 
damage caused by free oxygen radicals. There are 
several studies Which shows a decrease in the level 
of L-carnitine in seminal fluid in infertile men [10] 
(Sigman et al., 2006). A study by Vitali et al. Found 
that administration of l-carnitine increased the 
number of sperm motility and movement [11]. Also, 
the results of Lenzi et al. Showed a positive effect of 
L-carnitine on increased fertility, number and 
motility of sperm in 86 infertile men [9]. 
Therefore, in light of the above, the aim of this study 
was to investigate the effects of l-carnitine on the 
prevention of cyclophosphamide complications on 
testicular tissue in adult male rats. 
Introducing cyclophosphamide cyclophosphamide)) 
Cyclophosphamide is an anti-neoplastic drug (an 
anticancer drug) that converts to an active 
metabolising metabolite with the same effects as 
mostil (anticancer drug) in the body. The 
cyclophosphamide is well absorbed from the 
gastrointestinal tract and is widely distributed in body 
tissues and fluids, and from the cryopreservation of 
the brain goes on. This drug turns into active 
metabolites in the liver and ultimately excretes 
through the kidneys 
[12-14].
 
How to use and half-life of cyclophosphamide 
 
 
 
 
 
 
 
 
The way of consumption Start the effect Peak Effect Duration of work 
Edible 7 days 10-14 days 21 days 
Intravenous injection 7 days 10-14 days 21 days 
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El Carnitine, L-carnitine is an unnecessary amino 
acid. Deformed amino acids L-carnitine is produced 
in the form of androgens in almost all species of 
animals and even in some excellent herbaceous 
species[15]. This substance exists in two forms of di-
L-carnitine, a form of di-carnitine that is synthetic 
and not produced at the biological level. Carnitine 
with the formula C 7 H 15 NO3 is a betaine compound 
which, on the one hand, dissolves as an internal salt 
in water, and on the other hand exhibits strong 
hydroscopic properties. Its molecule has a molecular 
weight of 161.2 [15]. Cyclophosphamide is an 
anticancer drug used in the treatment of diseases such 
as lymphoma, leukemia, neuroblastoma, ovarian 
carcinoma, breast cancer, and autoimmune diseases 
(Dollery, 1999). Kang et al. (2011)[16,17] showed 
that administration of L-carnitine induced a 
significant decrease in apoptotic cells in the wall of 
the seminal tubes of diabetic rats (Kang et al., 2011). 
Research has shown that L-carnitine plays an 
important role in protecting the sperm membrane 
from free radicals and oxidative stress due to its 
antioxidant properties (Kerner and hoppel, 1998). 
McDermott et al. (1996)[18,19] discovered that 
chemotherapy with cyclophosphamide, in patients 
with breast cancer that has not yet experienced 
menstruation, causes a chemical infertility, as well as 
in the treatment of women with systemic lupus 
erythematosus, the drug Create untimely 
menstruation in them 
(McDermott et al., 1996). Parandak et al. (2014) 
[19,20] reported that daily intake of 2 grams of L-
carnitine supplementation for 2 weeks during 
endurance exercise reduced the effects of lipid 
peroxidation and muscle damage 
(Parandak et al., 2014). Premkumar et al. 
(2006)[20,21] also reported that saffron has 
prevented DNA damage from bone marrow cells in 
mice due to the use of anti-tumor drugs, synplatin, 
cyclophosphamide and mitomycin [21]. Bokser et al. 
(1990)[22] considered ovarian dysfunction in rats 
following cyclophosphamide due to degradation of 
granulose cells[22]. 
It has been shown that single-dose and intraperitoneal 
injection of cyclophosphamide causes the destruction 
and degradation of particles within the mitochondria 
and the smooth endoplasmic net of hepatocytes and 
also increases the level of hemoglobin 
malondialdehyde [23]. Kraemer et al. (2003)[24] 
stated that daily intake of 2 grams of L-carnitine 
supplementation during 3 weeks of resistance training 
reduces free radicals and also increases the synthesis 
of muscle structural proteins  [24]. 
 
RESEARCH METHODOLOGY: 
Methods and procedures for conducting the test 
How to select and maintain the animals tested 
The animals tested in this study included 48 Wistar 
male rats, which were completely randomized from 
Shiraz University of Medical Sciences and were 
tested at the experimental animals' laboratory. To 
feed animals, we used compressed food (pellets) from 
the feed and livestock feed company. The water used 
by the rats was plumbing water provided to them in 
plastic containers for drinking water in rats. Animals 
used in transparent macrolon cages of 20 × 55 × 55 
cm were covered with stainless steel mesh ceilings 
and the floor of the cages was covered with sawdust 
and wood chips. It should be noted that the wood 
chips in the cages were replaced every two days, and 
the cages were washed and disinfected with alcohol 
and soap. Ambient temperature °2±22  c and humidity 
was 55 ± 3 and the 12-hour light period and the 12-
hour dark period were provided. The floor and the 
equipment in it were disinfected by Saulen. 
Grouped animals tested 
In this study, 48 adult male Wistar rats were grouped 
in 8 groups. Mice were weighed before and after the 
test. 
Animals were categorized completely randomly in 
the following groups: 
- Control group: There are no animal treatments in 
this group, and animals only use ordinary water and 
food. 
- Sham group: In this group, the animals also receive 
the solvent volume given to the experimental groups 
as a gavage for the drug, i.e., the serum of 
physiology. 
- Experimental group 1: Group treated with 
cyclophosphamide (mg / kg 5) (vasegh et al., 2014). 
- Experimental group 2: The group treated with L-
carnitine (mg / kg 500) (Yari et al., 2009). 
- Experimental group 3: Group treated with 
cyclophosphamide (5 mg / kg) + lactartin (250 mg / 
kg). 
- Experimental group 4: Cyclophosphamide treated 
group (5 mg / kg) + lactartin (500 mg / kg). 
How to prepare and prescribe cyclophosphamide and 
carnitine 
The cyclophosphamide pill used in this study was 
packed in 10 packs (50 mg) from the pharmacy of 
Namazi Hospital in Shiraz. On the other hand, L-
carnitine powder was purchased from Sigma as a 100 
g vial. In order to prescribe cyclophosphamide and L-
carnitine, the drug dose ((cyclophosphamide 5 mg / 
kg body weight) and (L-carnitine 250, 500 and 1000 
mg / kg body weight) were used first (required 
values, weight And dissolved in normal saline. Then, 
given the weight of the rats, administration was made 
for 30 days. 
The method of measuring the concentration of LH, 
FSH and testosterone hormones 
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ELISA method was used to measure the 
concentration of LH, FSH and testosterone hormones. 
This method combines the specificity of antibodies 
and the sensitivity of simple enzyme measurements. 
 
Method of study of tissue sections 
Slides prepared from cross-sectional testicles of adult 
adult rats were separately studied by optical 
microscope with a magnification of 40 ×. In each 
slide, the average number of spermatogonium, 
spermatocyte, spermatid, sertoli and leydig cells in 
the spermatogonial tubes was performed in 20 
tubules per lam by counting with optical microscope 
and solvent counterpart. After counting the cells, a 
Nikon microscope was used for photomicrographs. 
Statistical analysis and statistical methods 
The crude numbers obtained by measuring serum 
concentrations of LH, FSH and testosterone 
hormones, as well as body weight, testicles and 
sexually transmitted cells in SPSS software were 
analyzed by one way ANOVA and tukey test for each 
separate test. They were compared with each other 
and their charts were plotted by one-way ANOVA 
based on the data obtained from the analysis of 
numbers. The values used are mean ± SD and SEM 
(p≤0.05). 
RESULTS:
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Fig1: Results of mean body weight in the studied groups 
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Fig 2:  shows the results of mean left testicle weight in the studied groups 
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Fig 3: Shows the results of the mean concentration of LH in the studied groups 
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Fig 4: Results of the mean concentration of FSH in the studied groups 
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Fig 5: Results of spermatogonial cells count in the studied 
groups
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Fig 6: shows the results of spermatocyte count in the studied groups 
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Fig 7:The results of the Leydig cell count in the studied groups 
 
DISCUSSION AND CONCLUSION: 
Interpretation of results related to body weight in rats 
In the present study, the mean weight of rats only 
decreases significantly in the cyclophosphamide 
group than in the control group. In other groups, there 
was no significant change in relation to each other. 
Studies have shown that cyclophosphamide interferes 
with appetite and nausea and vomiting[13,25], which 
can be due to stimulation of the chemical receptor 
located on the fourth ventricle in the inferior alveolar 
region [26]. It also causes toxic effects on the sexual 
organs, liver and proteinuria[25]. Lopez et al. (2004) 
[27]report the weight loss of mice in the group 
prescribed only cyclophosphamide [27]. Deleve 
2003[28] also observed a decrease in weight loss in 
the group that used the cyclophosphamide alone in a 
study on toxic effects of cyclophosphamide on the 
liver, due to the effects of cyclophosphamide toxicity 
on the liver, kidneys and other organs [28]. study by 
Das in 2002 found that cyclophosphamide-receptor 
rats significantly decreased weight (Das, 2002), 
which is consistent with the findings of the study. 
Therefore, it can be said that probably 
cyclophosphamide has been able to reduce body 
weight by inhibiting proteinuria and affecting the 
amount of fat due to low appetite, and decreased 
protein and fat mass. But if we want to express the 
role of L-carnitine, it should transfer the active fat 
from fat storage masses into mitochondria and act as 
a cofactor in the production of energy, and develop 
the process of production of middle-chain fatty acids 
and pyruvate as well as ketone bodies It also controls 
the internal environment of the cell and detoxifies it 
[29]. In the study, L-carnitine reduced abdominal fat 
resulting from a high-fat diet in mice [30]. In a study 
conducted on diabetic obese subjects, the findings 
showed that supplementation of two grams of L-
carnitine With Orlistat, it has found better results in 
improving lipid and lipid profiles than Orlistat alone 
[31]. A number of studies have shown that 
supplementation of L-carnitine can stimulate the 
increase of l-carnitine in different tissues and, 
consequently, increase the oxidation of fatty acids, 
and increase the oxidation of fatty acids in reducing 
fat mass [32-34]. 
Interpretation of the results of the mean left and right 
testicles in rats. 
In the present study, there was a significant decrease 
in the mean of left and right testicles in the 
cyclophosphamide receiving group compared to 
control and sham groups. On the other hand, in the 
groups receiving l-carnitine 500 mg / kg and 1000 
mg, the weight loss of the left and right testicles was 
significantly prevented. One of the reasons for the 
loss of testicular weight and atrophy of testicles is a 
disorder that disrupts spermatogenesis, such as 
cyclophosphamide. By creating free radicals and 
breaking DNA cells, this drug can cause apoptosis 
and necrosis. In other words, cyclophosphamide, by 
affecting the DNA molecule, inhibits the replication 
of the cells, resulting in a decrease in the number of 
spermatogonium, sperm, spermatid, spermatocyte 
cells and the testicular tissue is affected by 
oligospermia or azoospermia [35]. 
 Due to the fact that the LH hormone secretes 
testosterone from the interstitial cells, and 
testosterone with FSH causes spermatogenesis, 
decreasing testosterone release (Guyton and Hall., 
1996) decreases with decreasing LH as a result of 
spermatogenesis. By reducing the process 
Spermatogenesis The weight of the testicle also 
decreases. 
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Interpretation of the results of mean concentrations of 
LH, FSH and testosterone hormones in the studied 
groups. In this study, there was a significant decrease 
in the mean concentration of LH, FSH and 
testosterone in the cyclophosphamide receptor group 
compared to control and sham groups. Also, the mean 
concentration of these hormones in the groups 
receiving l-carnitine showed a significant increase 
compared to the cyclophosphamide recipient group. 
However, although the concentration of LH in the 
two groups of 250 mg / kg (250 mg / kg) and 500 
(500 mg / kg) and testosterone concentrations in the 
larvalent group (500 mg / kg) received a significant 
increase compared to the recipient group 
Cyclophosphamide showed but not within the control 
and control groups, and they also show significant 
differences. 
Interpretation of the results of spermatogonium, 
spermatocyte, spermatid, sertoli and leydig cells in 
the studied groups 
In the present study, there was a significant reduction 
in the number of spermatogonial, spermatocyte, 
spermatoid and leydig cells in the cyclophosphamide 
receiving group compared to the control group. 
However, the reduction in the number of these cells 
was prevented in the groups receiving l-carnitine at a 
dose of 1000 mg / kg (and sometimes at a dose of 500 
mg / kg). Which indicates the positive effects of l-
carnitine against the effects of cyclophosphamide 
active metabolites (such as acrolein)? In fact, El 
Carnitine has been able to protect cells from 
apoptosis and necrosis due to its potent antioxidant 
properties. Kang et al. (2011)[17] also found that 
administration of carnitine induced a significant 
reduction in apoptotic cells in the wall of the 
spermatozoon tubes. The results of Lenzi et al. 
Showed positive effects of l-carnitine on increased 
fertility, Showed the number and motility of sperm in 
86 infertile men [36]. Another study by Shrilatha et 
al. 2007, [37]revealed increased lipid peroxidation 
and the production of free radicals as a cause of 
destructive effects on Testicular tissue and 
spermatogenesis process [37]. Therefore, considering 
the above studies and the positive effects of l-
carnitine on testicular tissue cells, it can be argued 
that l-carnitine has been able to protect testicular 
tissue cells from cyclophosphamide damage due to its 
potent antioxidant properties. 
 
CONCLUSION: 
The results of this study showed that L-carnitine was 
dose-dependent in doses of 500 and 1000 mg / kg 
body weight, and somewhat reduced the testicular 
weight, spermatogonia, spermatocyte, spermatid, 
sertoli, leydig and serum concentrations Testosterone, 
LH and FSH inhibit hormones. So it can be used in 
therapeutic cases. 
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